Skip to main content
. 2023 Jan 12;11(3):306–319. doi: 10.1158/2326-6066.CIR-22-0454

Table 1.

Patient characteristics.

Fresh samples Paraffin samples
Total HPV+ HPV P Total HPV+ HPV P
Variables n = 55 (100.0) n = 37 (67.3) n = 18 (32.7) value n = 78 (100.0) n = 36 (46.2) n = 42 (53.8) value
Age medium (range) 56 (22–77) 55 (22–77) 54 (48–77) 0.002a 57 (22–80) 51 (22–74) 58 (36–80) 0.026a
Gender, N (%)
 Male 46 (83.6) 29 (52.7) 17 (30.9) 0.262 69 (88.5) 29 (37.2) 40 (51.3) 0.095
 Female 9 (16.4) 8 (14.5) 1 (1.8) 9 (11.5) 7 (9.0) 2 (2.6)
Smoking, N (%)
 No 21 (57.1) 18 (32.7) 3 (5.5) 0.022 38 (48.7) 21 (26.9) 17 (21.8) 0.116
 Yes 34 (42.9) 19 (34.5) 15 (27.3) 40 (51.3) 15 (19.2) 25 (32.1)
Anatomic site, N (%)
 Tonsil 46 (83.6) 34 (61.8) 12 (21.8) 37 (47.4) 23 (29.5) 14 (17.9)
 Base of tongue 4 (7.3) 2 (3.6) 2 (3.6) 0.037b 30 (38.5) 11 (14.1) 19 (24.4) 0.032b
 Soft palate 4 (7.3) 1 (1.8) 3 (5.5) 4 (5.1) 1 (1.3) 3 (3.8)
 Other 1 (1.8) 0 (0) 1 (1.8) 7 (9.0) 1 (1.3) 6 (7.7)
T Stage, N (%)
 T1 5 (9.1) 3 (5.5) 2 (3.6) 17 (21.8) 9 (11.5) 8 (10.3)
 T2 27 (49.1) 20 (36.4) 7 (12.7) 0.115b 31 (39.7) 16 (20.5) 15 (19.2) 0.110b
 T3 18 (32.7) 13 (23.6) 5 (9.1) 24 (30.8) 11 (14.1) 13 (16.7)
 T4 5 (9.1) 1 (1.8) 4 (7.3) 6 (7.7) 0 (0) 6 (7.7)
N Stage, N (%)
 N0 1 (1.8) 1 (1.8) 0 (0) 4 (5.1) 1 (1.3) 3 (3.8)
 N1 27 (49.1) 25 (45.5) 2 (3.6) 0.000b 24 (30.8) 21 (26.9) 3 (3.8) 0.000b
 N2 12 (21.8) 3 (5.5) 9 (16.4) 17 (21.8) 12 (15.4) 5 (6.4)
 N3 15 (27.3) 8 (14.5) 7 (12.7) 33 (42.3) 2 (2.6) 31 (39.7)
Tumor Stage, N (%)
 I 18 (32.7) 18 (32.7) 0 (0) 23 (29.5) 17 (21.8) 6 (7.7)
 II 10 (18.2) 10 (18.2) 0 (0) 0.000b 20 (25.6) 17 (21.8) 3 (3.8) 0.000
 III 11 (20.0) 9 (16.4) 2 (3.6) 10 (12.8) 2 (2.6) 8 (10.3)
 IV 16 (29.1) 0 (0) 16 (29.1) 25 (32.1) 0 (0) 25 (32.1)

at test.

bFisher exact test.